Inmode Ltd (INMD) |
|
59.95 2.23 (3.86%)
|
01-21 01:00 |
|
Open: |
58.66 |
Pre. Close: |
57.72 |
|
High:
|
61.81 |
Low:
|
58.66 |
|
Volume:
|
751,671 |
Market Cap:
|
1,966M |
|
|
|
|
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode Ltd. offers its products directly in the United States, Canada, the United Kingdom, Spain, Australia, and India, as well as indirectly through distributors in 46 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
61.88 - 62.126 |
62.126 - 62.337 |
|
Low:
|
58.001 - 58.295 |
58.295 - 58.549 |
|
Close:
|
59.439 - 59.922 |
59.922 - 60.338 |
|
Technical analysis |
as of: 2021-01-20 4:48:44 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 72.19 One year: 84.32 |
| Support: |
Support1: 51.14 Support2: 44.55 |
| Resistance: |
Resistance1: 61.81 Resistance2: 72.19 |
| Pivot: |
51.54 |
| Moving Average: |
MA(5): 57.47 MA(20): 50.53
MA(100): 41.66 MA(250): 34.73 |
| MACD: |
MACD(12,26): 3.47 Signal(9): 2.46 |
| Stochastic oscillator: |
%K(14,3): 89.50 %D(3): 90.45  |
| RSI: |
RSI(14): 82.77 |
| 52-week: |
High: 61.81 Low: 13.14 Change(%): 20.5 |
| Average Vol(K): |
3-Month: 66531 10-Days: 88273 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.INMD has closed below upper band by 4.1%. Bollinger Bands are 195.9% wider than normal. The large width of the bands suggest high volatility as compared to INMD's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Sun, 17 Jan 2021
Validea's Top Five Healthcare Stocks Based On Motley Fool - 1/17/2021 - Nasdaq
Tue, 12 Jan 2021
InMode Expects Record Fourth Quarter and Full Year 2020 Results, Fourth Quarter Revenue Between $74.5-$75M, Non-GAAP Earnings per Diluted Share Between $0.91-$0.93; Announces 2021 Full Year Revenue Guidance of $250- $260M - Yahoo Finance
Mon, 11 Jan 2021
InMode to Participate at the 2021 ICR Conference - Yahoo Finance
Mon, 11 Jan 2021
Zacks.com featured highlights include: Azure Power Global, Mueller Industries, H&E Equipment Services, Korea Electric Power and InMode - Yahoo Finance
Wed, 06 Jan 2021
InMode Announces Corporate Social Responsibility Strategy USA - PRNewswire
Sun, 03 Jan 2021
A Multi-Bagger Stock In The Making: InMode Has All The Right Traits - Seeking Alpha
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
33 |
| Shares Float (M) |
17 |
|
% Held by Insiders
|
42.45 |
|
% Held by Institutions
|
45.32 |
|
Shares Short (K)
|
1,580 |
|
Shares Short P. Month (K)
|
1,620 |
Stock Financials |
|
EPS
|
1.160 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
5.300 |
|
Profit Margin
|
32.57 |
|
Operating Margin
|
31.13 |
|
Return on Assets (ttm)
|
14.9 |
|
Return on Equity (ttm)
|
29.5 |
|
Qtrly Rev. Growth
|
49.2 |
|
Gross Profit (p.s.)
|
4.150 |
|
Sales Per Share
|
5.424 |
|
EBITDA (p.s.)
|
1.700 |
|
Qtrly Earnings Growth
|
47.60 |
|
Operating Cash Flow (M)
|
65 |
|
Levered Free Cash Flow (M)
|
42 |
Stock Valuations |
|
PE Ratio
|
51.68 |
|
PEG Ratio
|
|
|
Price to Book value
|
11.31 |
|
Price to Sales
|
11.05 |
|
Price to Cash Flow
|
30.22 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
